Andrea Lynn Johnstone
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$9.6MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $9.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 12, 2025 | NIH | SBIR Phase II Development of ultra-efficient antibodies for single cell mapping applications | $1.0M | Epicypher, Inc. |
| Feb 19, 2024 | NIH | SBIR Phase II Development of ultra-efficient antibodies for single cell mapping applications | $1.0M | Epicypher, Inc. |
| Aug 16, 2023 | NIH | SBIR Phase II Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease | $1.0M | Epicypher, Inc. |
| May 19, 2023 | NIH | SBIR Phase II Quantification of combinatorial epigenetic modifications using defined nucleosome standards | $1.0M | Epicypher, Inc. |
| Mar 10, 2023 | NIH | SBIR Phase II Development of ultra-efficient antibodies for single cell mapping applications | $1.0M | Epicypher, Inc. |
| Aug 12, 2022 | NIH | SBIR Phase II Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease | $978K | Epicypher, Inc. |
| May 27, 2022 | NIH | SBIR Phase II Quantification of combinatorial epigenetic modifications using defined nucleosome standards | $1.0M | Epicypher, Inc. |
| Feb 4, 2022 | NIH | SBIR Phase II Rapid quantification of nuclear citrullination in human neutrophils | $975K | Epicypher, Inc. |
| Sep 8, 2021 | NIH | SBIR Phase II Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease | $302K | Epicypher, Inc. |
| Jan 22, 2021 | NIH | SBIR Phase II Rapid quantification of nuclear citrullination in human neutrophils | $978K | Epicypher, Inc. |
| Dec 27, 2018 | NIH | SBIR Phase I Quantification of combinatorial epigenetic modifications using defined nucleosome standards | $300K | Epicypher, Inc. |
Peer ranks
Federal funding#67
Awards as PI#106
Patents#273
Companies
- Epicypher, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.